scispace - formally typeset
Y

Ying Mao

Researcher at Fudan University

Publications -  440
Citations -  12184

Ying Mao is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 49, co-authored 384 publications receiving 9287 citations. Previous affiliations of Ying Mao include University of Michigan & Fudan University Shanghai Medical College.

Papers
More filters
Journal ArticleDOI

Evidence for stroke-induced neurogenesis in the human brain

TL;DR: It is reported that in patients with stroke, cells that express markers associated with newborn neurons are present in the ischemic penumbra surrounding cerebral cortical infarcts, where these cells are preferentially localized in the vicinity of blood vessels.
Journal ArticleDOI

An open science resource for establishing reliability and reproducibility in functional connectomics

Xi-Nian Zuo, +85 more
- 09 Dec 2014 - 
TL;DR: The Consortium for Reliability and Reproducibility (CoRR) has aggregated 1,629 typical individuals’ resting state fMRI data from 18 international sites, and is openly sharing them via the International Data-sharing Neuroimaging Initiative (INDI).
Journal ArticleDOI

CGCG clinical practice guidelines for the management of adult diffuse gliomas

TL;DR: The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost and should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutionsinvolved in the cost regulation of cancer care in China.
Journal ArticleDOI

Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts.

TL;DR: DTI-based functional neuronavigation contributes to maximal safe resection of cerebral glioma with PT involvement, thereby decreasing postoperative motor deficits for both HGGs and low-grade gliomas while increasing high-quality survival for H GGs.
Journal ArticleDOI

MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.

TL;DR: It is demonstrated that the reference transcripts commonly used for quantitative PCR were unreliable for assessing EV miRNA and suggested that CSF EV mi RNA analysis of miR-21 may serve as a platform for glioblastoma biomarker development.